Cargando…
MicroRNA-181a suppresses norethisterone-promoted tumorigenesis of breast epithelial MCF10A cells through the PGRMC1/EGFR–PI3K/Akt/mTOR signaling pathway
BACKGROUND: Research suggests that hormone replacement therapy may increase the risk of breast cancer, and progestins such as norethisterone (NET) play a key role in this phenomenon. We have demonstrated that microRNA-181a (miR-181a) suppresses NET-promoted breast cancer cell survival. Nonetheless,...
Autores principales: | Cai, Guiju, Wang, Yuejiao, Houda, Tahiri, Yang, Chun, Wang, Lijuan, Gu, Muqing, Mueck, Alfred, Croteau, Stephane, Ruan, Xiangyan, Hardy, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974027/ https://www.ncbi.nlm.nih.gov/pubmed/33730679 http://dx.doi.org/10.1016/j.tranon.2021.101068 |
Ejemplares similares
-
Comprehensive Analysis of the Implication of PGRMC1 in Triple-Negative Breast Cancer
por: Xu, Xin, et al.
Publicado: (2021) -
PGRMC1 and PGRMC2 in uterine physiology and disease
por: Pru, James K., et al.
Publicado: (2013) -
PGRMC Proteins Are Coming of Age: A Special Issue on the Role of PGRMC1 and PGRMC2 in Metabolism and Cancer Biology
por: Cahill, Michael A., et al.
Publicado: (2021) -
Norethisterone‐induced cholestasis: A case report
por: Moussaoui, Safa, et al.
Publicado: (2022) -
Identification of PGRMC1 as a Candidate Oncogene for Head and Neck Cancers and Its Involvement in Metabolic Activities
por: Zhao, Yue, et al.
Publicado: (2020)